[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TW200514847A - Lactic acid bacteria having mucosal immunopotentiation effect - Google Patents

Lactic acid bacteria having mucosal immunopotentiation effect

Info

Publication number
TW200514847A
TW200514847A TW093125179A TW93125179A TW200514847A TW 200514847 A TW200514847 A TW 200514847A TW 093125179 A TW093125179 A TW 093125179A TW 93125179 A TW93125179 A TW 93125179A TW 200514847 A TW200514847 A TW 200514847A
Authority
TW
Taiwan
Prior art keywords
lactic acid
mucosal
acid bacteria
immunopotentiation effect
immunopotentiation
Prior art date
Application number
TW093125179A
Other languages
English (en)
Other versions
TWI354701B (zh
Inventor
Satoko Yamahira
Masamichi Toba
Hiroshi Okamatsu
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34213649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200514847(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of TW200514847A publication Critical patent/TW200514847A/zh
Application granted granted Critical
Publication of TWI354701B publication Critical patent/TWI354701B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/25Lactobacillus plantarum

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TW093125179A 2003-08-21 2004-08-20 Lactic acid bacteria having mucosal immunopotentiation effect TW200514847A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003297570 2003-08-21

Publications (2)

Publication Number Publication Date
TW200514847A true TW200514847A (en) 2005-05-01
TWI354701B TWI354701B (zh) 2011-12-21

Family

ID=34213649

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093125179A TW200514847A (en) 2003-08-21 2004-08-20 Lactic acid bacteria having mucosal immunopotentiation effect

Country Status (12)

Country Link
US (1) US7842495B2 (zh)
EP (1) EP1661983B1 (zh)
JP (1) JP3818319B2 (zh)
KR (1) KR101095712B1 (zh)
CN (1) CN100489086C (zh)
AU (1) AU2004267304B2 (zh)
CA (1) CA2535362C (zh)
DE (1) DE602004030922D1 (zh)
ES (1) ES2356315T3 (zh)
HK (1) HK1093355A1 (zh)
TW (1) TW200514847A (zh)
WO (1) WO2005019438A1 (zh)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2356315T3 (es) 2003-08-21 2011-04-06 Otsuka Pharmaceutical Co., Ltd. Bacterias ácido-lácticas que presentan un efecto de inmunopotenciación de las mucosas.
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
JP4688457B2 (ja) * 2004-09-10 2011-05-25 四国乳業株式会社 免疫増強組成物
US8182849B2 (en) 2005-02-23 2012-05-22 Otsuka Pharmaceutical Co., Ltd. Fermented tea beverage and tea beverage
ES2348064T3 (es) * 2005-02-23 2010-11-29 Otsuka Pharmaceutical Co., Ltd. Bebida de té fermentada y bebida de té.
FR2886817B1 (fr) * 2005-06-10 2007-08-24 Gervais Danone Sa Produit alimentaire enrichi en probiotique et appauvri en acides organiques
JP2007070249A (ja) * 2005-09-05 2007-03-22 Shinshu Univ 免疫機能調節剤、抗アレルギー剤、免疫調節用組成物及び抗アレルギー用組成物並びにこれらが含まれた食品
AU2006297895B2 (en) 2005-10-06 2011-09-01 Probi Ab Use of lactobacillus for treatment of virus infections
JP2007308419A (ja) * 2006-05-18 2007-11-29 Shinshu Univ 腸管免疫活性化剤及びIgA抗体産生促進剤、並びにこれらが含まれた食品、動物飼料及び医薬品
WO2008016108A1 (fr) * 2006-08-04 2008-02-07 Snow Brand Milk Products Co., Ltd. Agent de prévention d'une infection
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
US20080175899A1 (en) * 2007-01-19 2008-07-24 Ross Mairi R Formulation for promoting sinus health in nasal cavities
ATE478568T1 (de) * 2007-02-02 2010-09-15 May Amadeus Alexander Produkt mit lebenden probiotischen mikroorganismen
JP5144085B2 (ja) * 2007-02-20 2013-02-13 国立大学法人 東京大学 IgA抗体産生向上作用をもつ乳酸菌を含有する腸管免疫力増強剤
WO2009068474A1 (en) * 2007-11-29 2009-06-04 Carinsa. Creaciones Aromáticas Industriales, S. A. Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect
EP2138186A1 (en) * 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
EP2138187A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and infection
SG10201901259RA (en) * 2009-02-24 2019-03-28 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
JP5467785B2 (ja) * 2009-03-25 2014-04-09 大塚製薬株式会社 抗鳥インフルエンザウイルス抗体の産生促進剤
JP5324283B2 (ja) * 2009-03-27 2013-10-23 ミヤコ化学株式会社 感染防御剤
DE102009037089A1 (de) 2009-08-11 2011-03-03 Heller, Knut J., Prof. Dr. Zusammensetzung mit Stämmen von Lactobazillus fermentum
KR101840239B1 (ko) * 2010-01-28 2018-03-20 에이비-바이오틱스, 에스.에이. 장 염증의 치료에 사용하기 위한 프로바이오틱 조성물
WO2011108275A1 (ja) 2010-03-04 2011-09-09 株式会社ロッテ イムノグロブリンa分泌促進剤
TWI542353B (zh) * 2010-04-30 2016-07-21 豐華生物科技股份有限公司 用以抗陰道炎之含乳酸菌食品組合物及醫藥組合物
GB2484126A (en) * 2010-09-30 2012-04-04 Univ Plymouth Foodstuff fermented with lactic acid producing bacteria
WO2012063345A1 (ja) * 2010-11-11 2012-05-18 株式会社カザミ 免疫賦活剤及びそれを配合した免疫賦活組成物、並びに免疫賦活方法
KR101878525B1 (ko) * 2011-03-31 2018-07-13 오츠카 세이야쿠 가부시키가이샤 Qol 개선 또는 지속제
US9161957B2 (en) 2012-08-03 2015-10-20 Life Well Lived, Llc Compositions and methods for reducing blood alcohol content
JP2014125446A (ja) * 2012-12-26 2014-07-07 Hiroshima Univ 乳酸菌の細胞壁成分を含有する腸管免疫力増強剤
US9603880B2 (en) 2013-04-17 2017-03-28 Suntory Holdings Limited Composition containing bacterium belonging to genus lactobacillus
AU2014254812B2 (en) * 2013-04-17 2019-06-13 Suntory Holdings Limited Bacterium belonging to genus Lactobacillus
AP2016009641A0 (en) 2014-07-01 2016-12-31 Probi Usa Inc Bi-layer dual release probiotic tablets
KR20180093067A (ko) * 2015-12-25 2018-08-20 오츠카 세이야쿠 가부시키가이샤 겔상 식품 조성물
AR115757A1 (es) * 2018-07-13 2021-02-24 Cj Cheiljedang Corp Composición que comprende la cepa cjlp475 de lactobacillus plantarum y la cepa cjlp17 de lactobacillus plantarum y el uso de la misma
AR115758A1 (es) * 2018-07-13 2021-02-24 Cj Cheildang Corp Composición que comprende la cepa de lactobacillus plantarum cjlp475 y la cepa de lactobacillus plantarum cjlp243 y uso de la misma
CN111184067A (zh) * 2018-11-15 2020-05-22 内蒙古伊利实业集团股份有限公司 一种产芳香气体的酸奶及其制备方法
TWI689585B (zh) * 2018-12-10 2020-04-01 日商奧碧慧央集團股份有限公司 新穎乳酸菌株及包含新穎乳酸菌株之免疫賦活劑
JP7372112B2 (ja) * 2019-10-29 2023-10-31 大塚製薬株式会社 抗i型アレルギー剤
TWI823060B (zh) * 2021-02-26 2023-11-21 豐華生物科技股份有限公司 提升口腔免疫球蛋白a含量及抑制口腔病原菌之組成物及其用途
EP4319776A2 (en) * 2021-04-07 2024-02-14 Siolta Therapeutics, Inc. Pharmaceutical compositions for treating diseases
KR102462392B1 (ko) 2022-05-24 2022-11-03 주식회사 큐옴바이오 락토바실러스 플란타럼 q1 균주를 함유하는 점막 면역 증진용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE469875C (sv) 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JP4064481B2 (ja) 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 免疫賦活剤
JP4064480B2 (ja) 1996-10-11 2008-03-19 ハウスウェルネスフーズ株式会社 IgG抗体産生抑制剤
JP4601745B2 (ja) 1999-08-23 2010-12-22 ハウスウェルネスフーズ株式会社 免疫賦活効果を相乗的に増強した製剤
CN1444484A (zh) 2000-06-19 2003-09-24 穆科普罗泰科有限公司 用益生菌对粘膜表面的细菌或病毒感染进行治疗或免疫治疗及用于此的组合物
JP4667568B2 (ja) 2000-09-01 2011-04-13 ハウスウェルネスフーズ株式会社 免疫増強組成物
ES2356315T3 (es) 2003-08-21 2011-04-06 Otsuka Pharmaceutical Co., Ltd. Bacterias ácido-lácticas que presentan un efecto de inmunopotenciación de las mucosas.
ES2348064T3 (es) 2005-02-23 2010-11-29 Otsuka Pharmaceutical Co., Ltd. Bebida de té fermentada y bebida de té.

Also Published As

Publication number Publication date
CA2535362A1 (en) 2005-03-03
US20060182727A1 (en) 2006-08-17
KR20060119869A (ko) 2006-11-24
AU2004267304A2 (en) 2005-03-03
EP1661983B1 (en) 2011-01-05
CN100489086C (zh) 2009-05-20
CA2535362C (en) 2013-03-19
CN1849388A (zh) 2006-10-18
DE602004030922D1 (de) 2011-02-17
JP3818319B2 (ja) 2006-09-06
HK1093355A1 (en) 2007-03-02
ES2356315T3 (es) 2011-04-06
JPWO2005019438A1 (ja) 2006-10-19
KR101095712B1 (ko) 2011-12-20
AU2004267304B2 (en) 2009-03-12
EP1661983A4 (en) 2007-03-07
AU2004267304A1 (en) 2005-03-03
WO2005019438A1 (ja) 2005-03-03
TWI354701B (zh) 2011-12-21
EP1661983A1 (en) 2006-05-31
US7842495B2 (en) 2010-11-30

Similar Documents

Publication Publication Date Title
TW200514847A (en) Lactic acid bacteria having mucosal immunopotentiation effect
MY138070A (en) Novel probiotics for pet food applications
DK0986314T3 (da) Probiotisk mælkesyrebakterie til behandling af bakterielle infektioner associeret med SIDS
ATE421256T1 (de) Probiotische zusammensetzung
AU2003212265A1 (en) Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
BR9900972A (pt) Uso de uma associação de lactobacilos para a preparação de uma composição para tratamento de vaginoses e vaginites, e composições farmacêuticas assim preparadas.
AU2003247193A1 (en) Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
NO20051651L (no) Naeringspreparater inneholdende synbiotiske forbindelser
EP1854363B8 (en) Fermented tea beverage and tea beverage
WO2005110445A3 (en) Methods and compositions for the dietary management of autoimmune disorders
WO2004069156A3 (en) Inactivated probiotic bacteria and methods of use thereof
DE60137235D1 (de) L. salivarius-Stamm enthaltende probiotische Produkte
MXPA03001673A (es) Bacteria de acido lactico capaz de reducir una tendencia individual a desarrollar reacciones alergicas.
HK1073329A1 (en) Bacterium of the genus bifidobacterium and fermented foods using the same
MXPA04005346A (es) Uso de microorganismos para una distribucion dirigida de sustancias a partes especificas del intestino.
EP1812023B8 (en) Lactic acid bacteria as probiotic strains and compositions containing same
WO2003039260A3 (en) PROBIOTIC COMPOSITIONS
EP1611796A4 (en) FOOD COMPOSITION
MXPA04005002A (es) Bacterias lacticas y su uso en el tratamiento y la prevencion del cancer.
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
DE60227552D1 (de) Zusammensetzung zur verringerung der konzentration von pathogenen peptiden im darm
DE60210497D1 (en) Bifidobacterium longum
ITMI20041232A1 (it) Composizione nutraceutica contenente un numero elevato di fermenti lattici utile come sinbiotico
KR100508109B1 (ko) 코로나바이러스 및 유해 미생물의 증식을 억제하는 신규한 내산성 프로바이오틱 미생물 락토바실러스 사케이 프로바이오-61

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent